Status:
UNKNOWN
Use of Corifolitropin Alfa in Oocyte Donors
Lead Sponsor:
IVI Madrid
Collaborating Sponsors:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Instituto Valenciano de Infertilidad, IVI Alicante
Conditions:
Female Reproductive Problem
Infertility
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if corifollitropin alfa (long-term gonadotropin administration) is effective in a controlled ovarian stimulation protocol in oocyte donors compared to daily g...
Detailed Description
In recent years, increasingly advances have been developed in terms of controlled ovarian stimulation protocols. These improvements have also moved into the way of administration of the different trea...
Eligibility Criteria
Inclusion
- Women aged 18-35 years who meet the entry criteria for the IVI Donor Program:
- Weight \< 60 Kg
- Women with at least 6 antral follicles per ovary
- Women who will fit the protocoo during the period of the study
- Women who give written consent to participate in the test
Exclusion
- Women with basal antral follicle count above 20 or below 6.
- Women with comorbidities, in the judgement of the investigator, that may interfere with the trearment of ovarian stimulation.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT02213627
Start Date
October 1 2014
End Date
December 1 2015
Last Update
July 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI Madrid
Madrid, Madrid, Spain, 28023